Ericsson U B, Christensen S B, Thorell J I
Clin Immunol Immunopathol. 1985 Nov;37(2):154-62. doi: 10.1016/0090-1229(85)90146-1.
Sera from 228 patients with thyroid disease and 140 healthy subjects without clinical or biochemical evidence of thyroid disease, were tested using a sensitive solid-phase immunosorbent radioassay (RIA) and a passive hemagglutination test (TRC test) for thyroglobulin antibodies (Tg-ab). With the RIA technique, Tg-ab was found in 27% of the controls (36% of the women and 15% of the men), whereas only 0.7% of them were Tg-ab positive with the TRC test. All individuals with primary hypothyroidism were Tg-ab positive with the RIA, compared with only 56% with the TRC test. Tg-ab (RIA) were found in 43/53 (81%) of the patients with toxic diffuse goiter, and in 30-40% of the patients with toxic nodular goiter, toxic adenoma, atoxic goiter, and thyroid carcinoma, the TRC test being positive in 10-17% of these patients. The high prevalence of Tg-ab in the healthy population suggests that subclinical thyroiditis is more frequent than has been assumed from antibody measurements made with less sensitive methods, and is in agreement with the prevalences reported from autopsy studies.
采用灵敏的固相免疫吸附放射分析(RIA)和甲状腺球蛋白抗体(Tg-ab)被动血凝试验(TRC试验),对228例甲状腺疾病患者的血清以及140例无甲状腺疾病临床或生化证据的健康受试者的血清进行检测。采用RIA技术,在对照组中27%的人检测到Tg-ab(女性为36%,男性为15%),而采用TRC试验时,只有0.7%的人Tg-ab呈阳性。所有原发性甲状腺功能减退患者采用RIA时Tg-ab呈阳性,而采用TRC试验时只有56%呈阳性。在53例毒性弥漫性甲状腺肿患者中有43例(81%)检测到Tg-ab(RIA),在毒性结节性甲状腺肿、毒性腺瘤、非毒性甲状腺肿和甲状腺癌患者中,有30%-40%检测到Tg-ab,这些患者中采用TRC试验时有10%-17%呈阳性。健康人群中Tg-ab的高患病率表明,亚临床甲状腺炎比用敏感性较低的方法进行抗体检测所推测的更为常见,这与尸检研究报告的患病率一致。